Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) Short Interest Down 57.0% in March

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) was the target of a large decrease in short interest in March. As of March 13th, there was short interest totaling 3,182 shares, a decrease of 57.0% from the February 26th total of 7,403 shares. Based on an average daily trading volume, of 28,111 shares, the short-interest ratio is currently 0.1 days.

Coeptis Therapeutics Price Performance

Shares of COEPW opened at $0.01 on Thursday. Coeptis Therapeutics has a 1-year low of $0.00 and a 1-year high of $0.05. The firm has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.02.

Coeptis Therapeutics Company Profile

Coeptis Therapeutics is a clinical‐stage biopharmaceutical company focused on developing novel therapies for neurodegenerative and neuroinflammatory disorders. The company’s proprietary platform is based on engineered analogs of small heat shock proteins designed to modulate cellular stress responses, reduce inflammation and protect neurons from degeneration. Coeptis’s lead program is being advanced in amyotrophic lateral sclerosis (ALS), with additional preclinical studies underway in conditions such as multiple sclerosis and other central nervous system diseases.

Using its heat shock protein analog technology, Coeptis seeks to address the underlying pathology of neurodegeneration rather than merely managing symptoms.